News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Europe's Dramatic Decline in Pharmaceutical Production Threatens Health Sovereignty
Tuesday, December 30, 2025Europe faces a critical loss of pharmaceutical manufacturing dominance to China India and the US jeopardizing health sovereignty amid fragmented supply chains and shifting investments
European Commission and Parliament reach landmark political agreement on overhaul of EU pharmaceutical legislation
Monday, December 29, 2025EU institutions have reached a landmark political agreement to overhaul general pharmaceutical legislation reshaping incentives regulatory pathways and manufacturing obligations for companies operating in Europe
EU Unveils Sweeping Reforms for Pharma, Biotech, and Medical Device Sectors to Accelerate Innovation
Friday, December 26, 2025The European Union has announced comprehensive regulatory reforms targeting the pharma biotech and medical device industries to streamline approvals reduce bureaucracy and boost innovation across Europes life sciences sector
Sanofi's Wayrilz Approved in the EU as First BTK Inhibitor for Immune Thrombocytopenia
Thursday, December 25, 2025The European Commission has approved Sanofis Wayrilz rilzabrutinib as the first BTK inhibitor for adult patients with immune thrombocytopenia refractory to other treatments based on phase LUNA study results
Sanofi's Wayrilz Approved in the EU as First BTK Inhibitor for Immune Thrombocytopenia
Wednesday, December 24, 2025The European Commission has approved Sanofis Wayrilz rilzabrutinib as the first BTK inhibitor for adult patients with immune thrombocytopenia refractory to other treatments based on phase LUNA study results
Alvotech and Advanz Achieve Global First with Golimumab Biosimilar Launch in EU and UK
Tuesday, December 23, 2025Alvotech and Advanz Pharma have launched the worlds first golimumab biosimilar in the EU and UK on December marking a significant milestone in biopharma accessibility
U.S. FDA approves JASCAYD® (nerandomilast) tablets for progressive pulmonary fibrosis in adults
Tuesday, December 23, 2025Boehringer Ingelheim has received approval from the US Food and Drug Administration FDA for JASCAYD nerandomilast tablets to treat adults with progressive pulmonary fibrosis PPF The approval provides a new treatment option in the US for this serious...
European Union Reaches Landmark Agreement on Comprehensive Pharmaceutical Market Reform
Friday, December 19, 2025EU legislators have agreed on the most farreaching overhaul of the European pharmaceutical framework in over two decades reshaping incentives data exclusivity market access and RD obligations for drug makers operating in Europe
Cartography receives FDA IND approval and Fast Track status for CBI-1214 in colorectal cancer
Friday, December 19, 2025Cartography Biosciences has received approval from the US Food and Drug Administration FDA for its Investigational New Drug IND application for CBI the companys lead programme
Sanofi Gains European Commission Approval for Sarclisa in Combination with VRd for Newly Diagnosed Multiple Myeloma Patients
Thursday, December 18, 2025Sanofi has received European Commission approval for Sarclisa combined with VRd as a firstline treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant
